Manas AI

San Francisco, United States

Manas AI is a disruptive drug development AI firm that offers drugs for cancer and rare diseases.

$24.6M raised

Jan 2025

Seed

Top Investors

General CatalystGreylockReid Hoffman

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Manas AI raised?

Manas AI has raised $24.6M in total funding. The most recent round was Seed. The last funding was announced in January 2025.

Who are Manas AI's investors?

Manas AI's investors include General Catalyst, Greylock, Reid Hoffman.

Where is Manas AI headquartered?

Manas AI is headquartered in San Francisco, United States.

What does Manas AI do?

Manas AI is a disruptive drug development AI firm that offers drugs for cancer and rare diseases.

What stage is Manas AI at?

Manas AI is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 27, 2025.

MLA

"Manas AI — Funding & Investors." VCBacked, January 27, 2025, https://www.vcbacked.co/company/manas-ai. Accessed June 14, 2026.

APA

VCBacked. (2025). Manas AI — Funding & Investors. Retrieved June 14, 2026, from https://www.vcbacked.co/company/manas-ai

Wikipedia (cite web)

{{cite web |title=Manas AI — Funding & Investors |url=https://www.vcbacked.co/company/manas-ai |website=VCBacked |access-date=June 14, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 27, 2025.